Operating
Change in AR
Merck & Co. Change in AR remained flat by 0.0% to $272.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 346.7%, from $61.00M to $272.50M. Over 4 years (FY 2021 to FY 2025), Change in AR shows a downward trend with a -14.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ4 2025Feb 24, 2026
How to read this metric
A decrease is generally positive as it indicates faster collection of cash from customers.
Detailed definition
This measures the change in the amount of money owed to the company by customers for goods or services delivered on cred...
Peer comparison
Standard metric for all companies; peers in medical devices monitor this closely to manage working capital cycles.
Metric ID:
change_in_accounts_receivableHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $2.03B | $644.00M | $1.15B | $244.00M | $1.09B |
| YoY Change | — | -68.3% | +78.3% | -78.7% | +346.7% |
Range$244.00M – $2.03B
CAGR-14.4%
Avg YoY Growth+69.5%
Median YoY Growth+5.0%
Change in AR at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s change in ar?
- Merck & Co. (MRK) reported change in ar of $272.50M in Q4 2025.
- How has Merck & Co.'s change in ar changed year-over-year?
- Merck & Co.'s change in ar increased by 346.7% year-over-year, from $61.00M to $272.50M.
- What is the long-term trend for Merck & Co.'s change in ar?
- Over 4 years (2021 to 2025), Merck & Co.'s change in ar has grown at a -14.4% compound annual growth rate (CAGR), from $2.03B to $1.09B.
- What does change in ar mean?
- The change in money owed to the company by customers for past sales.